TRACER to support Akston Biosciences’ Phase 1 clinical study of AKS-452, an innovative anti-COVID-19 vaccine BEVERLY, Mass., USA & GRONINGEN, the Netherlands, Sept. 01, 2020 (GLOBE NEWSWIRE) -- Today, TRACER Europe B.V. (“TRACER”), a Clinical Research Organization (CRO) specializing in fast-track...